Literature DB >> 6516446

Metabolism of tenoxicam in rats.

S Ichihara, Y Tsuyuki, H Tomisawa, H Fukazawa, N Nakayama, M Tateishi, R Joly.   

Abstract

The structures of six metabolites of tenoxicam in rats (2 mg/kg, orally), elucidated by physicochemical analyses or the reverse-isotope dilution method, were 5'-hydroxytenoxicam (5% dose), 3-(methylsulphamoyl)-2-thiophenecarboxylic acid (9% dose), and the C-7 or C-8 O-glucuronide of tenoxicam (30% dose). The mechanism of formation of N-methylthiophenesulphimide, a possible precursor of 3-(methylsulphamoyl)-2-thiophenecarboxylic acid from tenoxicam, is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6516446     DOI: 10.3109/00498258409151471

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  6 in total

Review 1.  Tenoxicam. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  J P Gonzalez; P A Todd
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

Review 2.  Tenoxicam. An update of its pharmacology and therapeutic efficacy in rheumatic diseases.

Authors:  P A Todd; S P Clissold
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

3.  The effect of haemodialysis on the pharmacokinetics of tenoxicam in patients with end-stage renal disease.

Authors:  M S al-Ghamdi; F A al-Mohanna; Z H al-Mustafa; I S al-Saeed
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

4.  Metabolic disposition of the non-steroidal anti-inflammatory agent isoxicam in man.

Authors:  T F Woolf; A Black; A Sedman; T Chang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1992 Jan-Mar       Impact factor: 2.441

Review 5.  Clinical pharmacokinetics of tenoxicam.

Authors:  O G Nilsen
Journal:  Clin Pharmacokinet       Date:  1994-01       Impact factor: 6.447

Review 6.  Monooxygenase- and Dioxygenase-Catalyzed Oxidative Dearomatization of Thiophenes by Sulfoxidation, cis-Dihydroxylation and Epoxidation.

Authors:  Derek R Boyd; Narain D Sharma; Paul J Stevenson; Patrick Hoering; Christopher C R Allen; Patrick M Dansette
Journal:  Int J Mol Sci       Date:  2022-01-14       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.